212 related articles for article (PubMed ID: 18480585)
1. Successful treatment of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy and FDG-PET scan.
Takahashi T; Minato M; Tsukuda H; Yoshimoto M; Tsujisaki M
Intern Med; 2008; 47(10):975-9. PubMed ID: 18480585
[TBL] [Abstract][Full Text] [Related]
2. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin.
Hoshino A; Kawada E; Ukita T; Itoh K; Sakamoto H; Fujita K; Mantani N; Kogure T; Tamura J
Am J Hematol; 2004 Jul; 76(3):236-9. PubMed ID: 15224358
[TBL] [Abstract][Full Text] [Related]
4. Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
Wagner T; Brechemier D; Dugert E; Le Guellec S; Julian A; Hitzel A; Beyne-Rauzy O
Cancer Imaging; 2012 Jan; 12(1):7-12. PubMed ID: 22275725
[TBL] [Abstract][Full Text] [Related]
5. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
[No Abstract] [Full Text] [Related]
6. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
7. Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma.
Stewart DA; Kloiber R; Owen C; Bahlis NJ; Duggan P; Mansoor A; Bence-Bruckler I
Leuk Lymphoma; 2014 Sep; 55(9):2064-70. PubMed ID: 24188476
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of FDG-PET/CT for the diagnosis of intravascular large B-cell lymphoma presenting with fever of unknown origin and renal dysfunction].
Yago K; Yanagita S; Aono M; Matsuo K; Shimada H
Rinsho Ketsueki; 2009 Jun; 50(6):499-502. PubMed ID: 19571511
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.
Moskowitz CH; Schöder H; Teruya-Feldstein J; Sima C; Iasonos A; Portlock CS; Straus D; Noy A; Palomba ML; O'Connor OA; Horwitz S; Weaver SA; Meikle JL; Filippa DA; Caravelli JF; Hamlin PA; Zelenetz AD
J Clin Oncol; 2010 Apr; 28(11):1896-903. PubMed ID: 20212248
[TBL] [Abstract][Full Text] [Related]
11. [Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
Ishikawa T; Fukumi T; Moriyama T; Murakami H; Nagakita K; Yoshioka T; Makita M; Shinno Y; Sunami K
Rinsho Ketsueki; 2019; 60(10):1455-1461. PubMed ID: 31695007
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.
Adams HJ; Nievelstein RA; Kwee TC
Br J Haematol; 2015 Jul; 170(2):185-91. PubMed ID: 25833790
[TBL] [Abstract][Full Text] [Related]
13. Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects.
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Acta Radiol; 2016 Jun; 57(6):733-41. PubMed ID: 26297729
[TBL] [Abstract][Full Text] [Related]
14. [Intravascular Large B-cell Lymphoma: a Clinical Analysis of 17 Cases].
Yang JJ; Chen XC; Tang Y; Shen K; Xie LP; Liu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):145-147. PubMed ID: 29737107
[TBL] [Abstract][Full Text] [Related]
15. [Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].
Masaki Y; Miki M; Sakai T; Sawaki T; Fukushima T; Umehara H
Brain Nerve; 2011 May; 63(5):435-41. PubMed ID: 21515922
[TBL] [Abstract][Full Text] [Related]
16. Segmental tandem triplication of the MLL gene in an intravascular large B-cell lymphoma with multisystem involvement: a comprehensive morphologic, immunophenotypic, cytogenetic, and molecular cytogenetic antemortem study.
Deisch J; Fuda FB; Chen W; Karandikar N; Arbini AA; Zhou XJ; Wang HY
Arch Pathol Lab Med; 2009 Sep; 133(9):1477-82. PubMed ID: 19722759
[TBL] [Abstract][Full Text] [Related]
17. Intravascular Large B-Cell Lymphoma Complicated by Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis that was Successfully Treated with Rituximab-Containing Chemotherapy.
Tsuda M; Nakashima Y; Ikeda M; Shimada S; Nomura M; Matsushima T; Takahashi S; Aishima S; Oda Y; Shiratsuchi M; Takayanagi R
J Clin Exp Hematop; 2015; 55(1):39-43. PubMed ID: 26106006
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
Yang DH; Min JJ; Song HC; Jeong YY; Chung WK; Bae SY; Ahn JS; Kim YK; Bom HS; Chung IJ; Kim HJ; Lee JJ
Eur J Cancer; 2011 Jun; 47(9):1312-8. PubMed ID: 21334197
[TBL] [Abstract][Full Text] [Related]
19. Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab.
Kusaba T; Hatta T; Tanda S; Kameyama H; Tamagaki K; Okigaki M; Inaba T; Shimazaki C; Sasaki S
Clin Nephrol; 2006 Mar; 65(3):222-6. PubMed ID: 16550755
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea.
Hong JY; Kim HJ; Ko YH; Choi JY; Jung CW; Kim SJ; Kim WS
Acta Haematol; 2014; 131(1):18-27. PubMed ID: 24021554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
